Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Oncology · Esophageal Cancer

What Causes the Different Types of Esophageal Cancer?

At a Glance

Esophageal squamous cell carcinoma is most associated with smoking, heavy alcohol use, and chronic irritation, while adenocarcinoma is linked mainly to long-term reflux, Barrett’s esophagus, and central obesity. These are risk factors, not proof of a personal cause.

Esophageal cancer is not a single disease. The esophagus—the muscular tube that carries food from your throat to your stomach—is lined with different types of cells. The type of cancer a person develops depends on which specific cells become abnormal. Squamous cell carcinoma usually develops in the upper or middle part of the esophagus and is most strongly associated with a history of smoking, heavy alcohol use, and certain dietary factors. Adenocarcinoma typically forms in the lower esophagus near the stomach and is strongly linked to chronic acid reflux, a condition called Barrett’s esophagus, and central obesity.

Understanding the differences between these two main subtypes helps explain the different risk factors associated with them.

A Note on Risk Factors vs. Causes: It is natural to search for a reason after a cancer diagnosis, but it is important to know that medical research identifies risk factors—things that increase probability across a large population—not definitive personal causes [1]. Having a risk factor does not mean you caused your cancer. Many people with esophageal cancer have no clear explanation, and an individual diagnosis is usually the result of a complex mix of susceptibility and exposures [2].

Squamous Cell Carcinoma (SCC)

The inner lining of most of your esophagus consists of flat, thin cells called squamous cells. When these cells undergo genetic changes and grow out of control, it results in squamous cell carcinoma. This type of cancer is most frequently found in the upper and middle sections of the esophagus [3] [4].

SCC is generally associated with environmental and lifestyle factors that can chronically irritate the esophageal lining over time:

  • Tobacco and Alcohol: Smoking and heavy alcohol use are well-established risk factors for SCC [5]. When combined, tobacco and alcohol significantly amplify inflammation and DNA damage in the esophageal cells [6] [7].
  • Thermal Exposure: Some observational studies have associated SCC with regularly drinking very hot beverages (such as tea steeped at high temperatures), which may cause repeated thermal irritation to the esophagus [8]. Allowing hot drinks to cool to a comfortable temperature is a sensible precaution.
  • Diet and Nutrition: Observational studies have linked a lower intake of fresh fruits and vegetables (specifically carotenes and lutein) and certain minerals like selenium and zinc to a higher risk of SCC [9] [10]. However, this may reflect a person’s overall nutritional status rather than proving that a single deficiency causes cancer. Do not start high-dose supplements without consulting your doctor, as they are not a proven cancer treatment.
  • Esophageal Stasis: Conditions that cause food to pool and sit in the esophagus over a long period, such as achalasia (a condition where the esophagus fails to empty properly), can also lead to long-term irritation and contribute to SCC risk [11].

Adenocarcinoma

Adenocarcinoma starts in glandular cells—cells that produce mucus. It typically appears in the lower esophagus near the junction with the stomach, often as a response to chronic injury [12].

The risk factors for adenocarcinoma are closely linked to reflux and metabolic pathways:

  • Chronic Acid Reflux (GERD): Frequent, long-standing acid reflux is a major associated risk factor for adenocarcinoma [13] [14]. Over time, stomach acid repeatedly washes into the lower esophagus, altering the cellular environment.
  • Barrett’s Esophagus: In response to continuous acid exposure, the normal flat cells of the lower esophagus can be replaced by glandular cells, a change called metaplasia [12]. This condition is known as Barrett’s esophagus, and it is the principal recognized precursor to esophageal adenocarcinoma [15]. However, most people with Barrett’s will never develop cancer [16]. It is also important to note that many adenocarcinomas are diagnosed without any prior known history of Barrett’s [17].
  • Central Obesity: Carrying excess weight around the midsection increases physical pressure on the stomach, which can worsen acid reflux [13]. Additionally, fat tissue acts as an active organ, releasing inflammatory signals and hormones that may contribute to cancer risk through other metabolic pathways [18] [19].

Important Safety Note: If you have been diagnosed with esophageal cancer, do not attempt a restrictive diet or intentional weight loss without your oncology team’s direct guidance. Esophageal cancer and its treatments often cause difficulty swallowing and dangerous, unintentional weight loss. Maintaining your nutritional intake and physical strength is a critical priority for your care.

Common questions in this guide

Why do squamous cell carcinoma and adenocarcinoma have different risk factors?
They begin in different cell types and usually occur in different parts of the esophagus. Squamous cell carcinoma begins in the flat lining cells and is more associated with smoking and heavy alcohol use, while adenocarcinoma begins in gland-producing cells near the stomach and is more associated with long-term reflux, Barrett's esophagus, and central obesity.
Does acid reflux mean I will develop esophageal cancer?
No. Long-standing, frequent acid reflux increases the risk of esophageal adenocarcinoma and can lead to Barrett's esophagus, but most people with Barrett's never develop cancer. A risk factor changes probability; it does not predict what will happen to one person.
How are smoking and alcohol connected to esophageal cancer?
Smoking and heavy alcohol use are well-established risk factors for esophageal squamous cell carcinoma. Using both can increase irritation, inflammation, and DNA damage more than either exposure alone. This association does not mean you caused your cancer.
What is Barrett's esophagus, and why does it matter?
Barrett's esophagus is a change in which the normal flat cells in the lower esophagus are replaced by gland-producing cells after long-term acid exposure. It is the main recognized condition that can come before adenocarcinoma, but most people with Barrett's do not develop cancer, and some adenocarcinomas are diagnosed without a known history of Barrett's.
Can my diet, weight, or a past esophageal condition explain my cancer?
Central obesity is associated with adenocarcinoma, while low intake of fruits and vegetables, certain nutritional patterns, and achalasia-related food stasis have been associated with squamous cell carcinoma. These findings describe population-level risk and cannot identify a single cause for an individual diagnosis. If you have cancer, do not begin a restrictive diet or intentional weight loss without guidance from your oncology team.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific cell type (histology) and exact location of my tumor, and how do those details affect my treatment options?
  2. 2.Has my tumor been tested for relevant biomarkers (such as HER2, PD-L1, or mismatch-repair status) that might open up targeted therapy options?
  3. 3.If my tumor is in the lower esophagus, is there evidence of Barrett's esophagus or dysplasia nearby, and does that change my management?
  4. 4.I want to maintain my strength during treatment; can you refer me to an oncology dietitian, especially if I am having trouble swallowing?
  5. 5.Are there any clinical trials appropriate for my specific tumor subtype, stage, and biomarker profile?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Current management of Barrett esophagus and esophageal adenocarcinoma.

    Singh T, Sanghi V, Thota PN

    Cleveland Clinic journal of medicine 2019; (86(11)):724-732 doi:10.3949/ccjm.86a.18106.

    PMID: 31710585
  2. 2

    Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

    Thrift AP, Kendall BJ

    Gastrointestinal endoscopy clinics of North America 2026; (36(1)):49-68 doi:10.1016/j.giec.2025.05.006.

    PMID: 41260772
  3. 3

    Analysis of the influencing factors in the long-term survival of esophageal cancer.

    Rui W, Li C, Da Q, et al.

    Frontiers in oncology 2023; (13()):1274014 doi:10.3389/fonc.2023.1274014.

    PMID: 38304026
  4. 4

    Survival outcomes of neoadjuvant chemoradiation followed by surgery versus definitive chemoradiation in ESCC: real-world data.

    Alhalabi A, Abdo T, Sabbagh S, et al.

    Frontiers in oncology 2025; (15()):1658595 doi:10.3389/fonc.2025.1658595.

    PMID: 41415557
  5. 5

    Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda.

    Okello S, Churchill C, Owori R, et al.

    BMC cancer 2016; (16()):446 doi:10.1186/s12885-016-2492-x.

    PMID: 27400987
  6. 6

    Age-related remodelling of oesophageal epithelia by mutated cancer drivers.

    Yokoyama A, Kakiuchi N, Yoshizato T, et al.

    Nature 2019; (565(7739)):312-317 doi:10.1038/s41586-018-0811-x.

    PMID: 30602793
  7. 7

    Network toxicology reveals collaborative mechanism of 4NQO and ethanol in esophageal squamous cell carcinogenesis.

    Yuan J, Guo J, Wang Y, et al.

    Biochemistry and biophysics reports 2025; (43()):102187 doi:10.1016/j.bbrep.2025.102187.

    PMID: 40800605
  8. 8

    Tea drinking and the risk of esophageal cancer: focus on tea type and drinking temperature.

    Lin S, Xu G, Chen Z, et al.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2020; (29(5)):382-387 doi:10.1097/CEJ.0000000000000568.

    PMID: 32740163
  9. 9

    Very hot tea drinking increases esophageal squamous cell carcinoma risk in a high-risk area of China: a population-based case-control study.

    Yang X, Ni Y, Yuan Z, et al.

    Clinical epidemiology 2018; (10()):1307-1320 doi:10.2147/CLEP.S171615.

    PMID: 30310324
  10. 10

    Africa's Oesophageal Cancer Corridor: Geographic Variations in Incidence Correlate with Certain Micronutrient Deficiencies.

    Schaafsma T, Wakefield J, Hanisch R, et al.

    PloS one 2015; (10(10)):e0140107 doi:10.1371/journal.pone.0140107.

    PMID: 26448405
  11. 11

    PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome.

    Munari FF, Cruvinel-Carloni A, Lacerda CF, et al.

    Infectious agents and cancer 2018; (13()):43 doi:10.1186/s13027-018-0216-3.

    PMID: 30619505
  12. 12

    Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition.

    Nowicki-Osuch K, Zhuang L, Jammula S, et al.

    Science (New York, N.Y.) 2021; (373(6556)):760-767 doi:10.1126/science.abd1449.

    PMID: 34385390
  13. 13

    Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.

    Kunzmann AT, Thrift AP, Cardwell CR, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2018; (16(8)):1229-1236.e4 doi:10.1016/j.cgh.2018.03.014.

    PMID: 29559360
  14. 14

    The Immune Underpinnings of Barrett's-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators.

    Tambunting L, Kelleher D, Duggan SP

    Cellular and molecular gastroenterology and hepatology 2022; (13(5)):1297-1315 doi:10.1016/j.jcmgh.2022.01.023.

    PMID: 35123116
  15. 15

    Esophageal Adenocarcinoma: Screening, Surveillance, and Management.

    Mansour NM, Groth SS, Anandasabapathy S

    Annual review of medicine 2017; (68()):213-227 doi:10.1146/annurev-med-050715-104218.

    PMID: 27618753
  16. 16

    Insights Into the Pathophysiology of Esophageal Adenocarcinoma.

    Quante M, Graham TA, Jansen M

    Gastroenterology 2018; (154(2)):406-420 doi:10.1053/j.gastro.2017.09.046.

    PMID: 29037468
  17. 17

    Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.

    Sawas T, Killcoyne S, Iyer PG, et al.

    Gastroenterology 2018; (155(6)):1720-1728.e4 doi:10.1053/j.gastro.2018.08.036.

    PMID: 30165050
  18. 18

    Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma.

    Elliott JA, Reynolds JV

    Frontiers in oncology 2021; (11()):627270 doi:10.3389/fonc.2021.627270.

    PMID: 33777773
  19. 19

    Circulating Levels of Inflammatory and Metabolic Biomarkers and Risk of Esophageal Adenocarcinoma and Barrett Esophagus: Systematic Review and Meta-analysis.

    Xie SH, Rabbani S, Ness-Jensen E, Lagergren J

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020; (29(11)):2109-2118 doi:10.1158/1055-9965.EPI-20-0572.

    PMID: 32855267

This page is for informational purposes only and does not constitute medical advice. It describes population-level risk factors rather than proving the cause of an individual esophageal cancer; discuss your situation with your oncology team.

Get notified when new evidence is published on Carcinoma of esophagus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.